Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4270PDF: 1747HTML: 1100 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1321PDF: 825HTML: 10033cover letter to the editor: 164tile page: 245 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3343PDF: 1284HTML: 1855Fig.1: 195Fig. 2: 198 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3257PDF: 1335HTML: 2618 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2749PDF: 1792HTML: 3655Pellagatti Fig 1: 207Pellagatti Fig. 2: 202 -
A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 Ophthalmic vein thrombosis following Covid
1279PDF: 451HTML: 385 -
THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA
2555PDF: 820HTML: 14936Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 294 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2895PDF: 873HTML: 1572 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1562PDF: 963HTML: 177 -
Thalidomide treatment for thrombocytopenia secondary to hypersplenism in children with β-thalassemia major: a case series Thalidomide treatment for thrombocytopenia
862PDF: 723HTML: 106 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1578PDF: 797HTML: 155 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1745PDF: 560HTML: 271







